FDA Inspection 1005033 — ONY Biotech, Inc.
The FDA completed an inspection of ONY Biotech, Inc. on Mar 2, 2017 in Amherst, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 2, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Amherst, NY (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)